Skip to main content
. 2020 Jan 7;8:e8288. doi: 10.7717/peerj.8288

Figure 9. The signature-related genes in the cohorts.

Figure 9

(A, B, C) ATIC in the cohorts stratified by M stages (M = 0 indicated M0, M = 1 indicated M1), survival outcome (fustat = 0 indicated alive, fustat = 1 indicated dead) and tumor stages(1–4); (D, E) BNIP3 in the cohorts stratified by M stages (M = 0 indicated M0, M = 1 indicated M1), tumor stages(1–4); (F, G) EIF4EBP1 in the cohorts stratified by survival outcome (fustat = 0 indicated alive, fustat = 1 indicated dead) and gender (gender = 0 indicated female, gender = 1 indicated male); (H, I, J) ERO1A in the cohorts stratified by gender (gender = 0 indicated female, gender = 1 indicated male), tumor stages(1–4) and T stages (1–4); (K, L) FADD in the cohorts stratified by age and gender (gender = 0 indicated female, gender = 1 indicated male); (M, N, O, P) TP63 in the cohorts stratified by survival outcome (fustat = 0 indicated alive, fustat = 1 indicated dead), gender (gender = 0 indicated female, gender = 1 indicated male), M stages (M = 0 indicated M0, M = 1 indicated M1) and tumor stages (1–4).